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a b s t r a c t
Dendritic cells (DCs) are readily infected by inﬂuenza viruses and play a crucial role in reg-
ulating host innate and adaptive immune responses to viral infection. The aims of this
study are to characterize the dynamic changes in the numbers and maturation status of
dendritic cells present in the lung and lung-associated lymph nodes (LALNs) in the model
of a non-human primate (NHP) infected by inﬂuenza A virus (IAV). Cynomolgus macaques
were infected with inﬂuenza A virus (H3N2) via bronchoscopy. Flow cytometry was used to
analyze the DC numbers, maturation status and subsets during the time of acute infection
(days 1, 2, 3, 4, 7) and the resolution phase (day 30). A dramatic increase in the numbers of
inﬂuenza A virus-infected CD11c+CD14− myeloid dendritic cells (mDCs) and CD11c-CD123+
plasmacytoid dendritic cells (pDCs) were observed from day 1 to day 4 and peak up from day
7post-infection. In lung and lung-associated lymphnodes, thenumbers andmaturation sta-
tus of myeloid dendritic cells and plasmacytoid dendritic cells increased more slowly than
those in the lung tissues. On day 30 post-infection, inﬂuenza A virus challenge increased
the number of myeloid dendritic cells, but not plasmacytoid dendritic cells, compared with
baseline. These ﬁndings indicate that dendritic cells are susceptible to inﬂuenza A virus
infection, with the likely purpose of increasing mature myeloid dendritic cells numbers inTR
AC
TE
Dthe lung and lung and lung-associated lymphnodes, which provides important new insights
into the regulation of dendritic cells in a non-human primate model.IntroductionRE
Inﬂuenza A virus (IAV) is negative-stranded, segmented RNA
virus, an important human pathogen that causes worldwide
epidemics yearly and pandemics sporadically.1 The virus is
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responsible for substantial morbidity and mortality, with an
average of over 100,000 hospitalizations and approximately
20,000 deaths annually in the United States.2–5atory Research Institute, 2425 Ridgecrest Drive, SE, Albuquerque,
An important paradigm strongly suggests that the lung
damage arising from IAV consists of an excessive host
response characterized by a rapid, inﬂux of inﬂammatory
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ells into the lungs. Indeed, the respiratory portal serves as
n important entry site for pathogenic organisms, but it is
lso a primary infection site of all mammalian inﬂuenza
iruses. Maines et al. have reported that the speciﬁc glycan
eceptors on the apical surface of the respiratory tract were
ound to bind hemagglutinin of the 2009 A virus (H1N1).6
endritic cells (DCs) are key players in antiviral innate immu-
ity and acquired immune responses development,which can
onstruct a networkwithin epitheliumand submucosa of con-
ucting airway as well as in lung parenchyma, where they can
e found both on alveolar surfaces and in the vascular com-
artment of the lung.7–10 Furthermore, mature DCs efﬁciently
resent antigens and initiate adaptive immune response by
igrating into lymphoid tissue to present processed viral anti-
ens to T lymphocytes.11–13 At least two subsets of DCs have
een described in humans: the CD11c+ myeloid DCs, and the
D11c-CD123+ plasmacytoid DCs (pDCs), which express a dif-
erent repertoire of pattern recognition receptors and show a
ifferential response to various microbial stimuli.14
At present, pulmonary DCs have been studied in models
f bacterial infection and allergic airway sensitization, but
heir role in respiratory viral infection is still unclear. In a
ouse model, IAV infection has been found to increase the
umber of DC in the respiratory tract, but these were short-
ived DCs.15 Similar increases in the number of lung DCs
ave also been described following respiratory syncytial virus
RSV)16 infection and Sendai virus17 infection in mice. How-
ver, there are great differences ofDCs characteristics between
uman and murine. For example, human pDC characteristi-
ally express high levels of IL-3 receptor alpha chain (CD123),
ut in the mouse, pDC do not normally express CD123. How-
ver, non-human primate (NHP) DCs have the same markers
nd functions as human DCs. NHP model, therefore, is help-
ul for us to reveal the relationship between IVA infection and
ung DCs. A better understanding of the interplay of IAV with
Cs may facilitate the development of an effective vaccine.
In this study, we have focused on analyzing innate immune
esponse of NHP DCs in response to an infection with IAV in
ung and lung associated lymphoid node (LALN).
aterials and methods
nimals
ynomolgus macaques were purchased from a colony located
t the Lovelace Respiratory Research Institute (LRRI) animal
acilities. All animals (weight: 2.6± 1.2 kg) were male and their
ges were 6–9 years old when infected. The animals were
creened for active RSV, inﬂuenza, and parainﬂuenza infec-
ions. All studies were approved by the LRRI Institutional
nimal Care and Use Committee.
AV preparation
tudy design
RE
TRontrol animals (n=4) were instilled with sterile media and
nalyzed at day 4 following instillation. In low dose of IAV
nfection group (1× 106 PFU), blood was collected from ani-
als at day 1 (n=4), 2 (n=4), 3 (n=4), 4 (n=4), 7 (n=4) and 304;18(4):406–413 407
(n=4) post-infection. Additionally, in high dose of IAV infec-
tion group (2× 106 PFU), scheduled blood test was performed
at day 1 (n=4) and 2 (n=4) post-infection.
Bronchoscopic instillation of IAV
Instillations were performed in all groups via a pediatric bron-
choscope (FB-10x; Pentax Medical Company, Montvale, NJ).
Speciﬁcally, each animal was given 10mg ketamine/kg body
weight mixed with 2mg xylazine/kg body weight intramus-
cularly. Anesthesia was further induced by 2–3% isoﬂurane
by mask until sufﬁciently anesthetized. An endotracheal
tube was placed into the trachea and 2–3% isoﬂurane was
maintained via endotracheal tube throughout the instillation
procedures. Following adequate anesthesia, the bronchoscope
was inserted into both right and left caudal lobes for instilla-
tion of IAV strain HKx31 (H3N2) (low dose, 1× 106 PFUs/lobe)
diluted in 1mL of cell culture media. For studies in control
animals, both lungs were instilled with 1mL of media in each
lobe.
To facilitate dispersion of the inoculant into the lung
periphery, a syringe containing inoculant was expelled into
the catheter followed by multiple injections of air. Imme-
diately after inoculation, anesthetic was stopped and the
endotracheal tube was disconnected from the anesthesia
machine. The endotracheal tube was left in the trachea and
the animal was moved to a separate room under observation
by the veterinarian or veterinary staff until arousal and the
endotracheal tube removed. Animals usually recoveredwithin
20–30min and resumed normal activities.
Tissue harvest
At each time point following IVA infection and blood collec-
tion, the animals (n=4 for each time point) were euthanized by
increasing the isoﬂurane concentration up to 5% as described
above and then exsanguination was performed by cardiac or
arterial puncture in a bio-hood. Anecropsy procedurewas per-
formed immediately and the lungs were collected to provide
materials for a variety of analyses. Speciﬁcally, the middle
lobe was inﬂated with 4% paraformaldehyde and was treated
overnight at 4 ◦C. A part of fresh lung tissues from the lower
lobes (about 3–5 g) were collected and immediately placed in
5% RPMI.
Isolation of lung mononuclear cells (MNCs)
Lung mononuclear cells were isolated as previously
described.18 Brieﬂy, lungs were minced and digested with
Liberase Blendzymes 3 (Roche, Indianapolis, IN) and DNase
I (Sigma, St. Louis, MO) solution for 90min at 37 ◦C. After
digestion, lung cells were dispersed by shearing through a
20-gauge needle, followed by ﬁltration through a nylon screen
cell strainer (70m) to remove debris. Lung mononuclear cells
(LMNCs) were then separated by a 30% Percoll (Amersham,
Piscataway, NJ). Single cell suspensions were washed, con-
CT
EDtaminating erythrocytes were lysed using lysis buffer (0.15M
NH4Cl, 1mM KHCO3, and 0.1mM EDTA), and viable cells were
counted by trypan blue exclusion.
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Fig. 1 – CD11c+CD14− DCs rapidly and dramatically
increased in the lungs of monkeys following IVA infection.
Cynomolgus macaques were infected with IAV (H3N2) via
bronchoscopy. The lung cells were isolated and stained for
ﬂow cytometry analysis at days 1–4, 7 and 30 following IAV
infection (n=4/group). Data are expressed as mean
percentages±SEM. * indicates p<0.05, ** denotes p<0.01 as
A
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Harvest of LALN
LALNs were removed carefully. The LALNs were placed in petri
dishes containing RPMI 1640 medium supplemented with
penicillin and streptomycin (Sigma Chemical Co., St. Louis,
MO) and teased apart with ﬁne-toothed tweezers.
LALN cells were centrifuged at 230× g at 4 ◦C for 10min and
resuspended in complete medium, which consisted of RPMI
1640 medium supplemented with penicillin and streptomycin
(Sigma) and 2% heat-inactivated fetal calf serum (GIBCO-BRL,
Gaithersburg, MD). Then cells were resuspended in warm
(37 ◦C) lysing buffer [0.17M NH4Cl, 0.01M KHCO3, 0.1M EDTA
(pH 7.3)] for 5min to remove erythrocytes, centrifuged, and
washed once again. LALN and spleen cells were adjusted to a
ﬁnal concentration of 5× 106 cells per mL.
Flow cytometry
For investigation of lung DCs surface antigen expression,
MNCs were washed and spun to pellet. Lung DCs were
then suspended in staining buffer (PBS containing 2% fetal
bovine serum) at concentration of 1× 106/mL. Cells were
placed in 200L volumes into each tube and again spun
to pellet. Fluorescein isothiocyanate (FITC)-conjugated anti-
CD14, PE-conjugated anti-CD80, anti-CD83 and anti-CD86,
PerCP-conjugated anti-HLA-DR and antigen-presenting cell
(APC)-conjugated anti-CD11c antibodies (BD Pharmingen)
were used for surface staining together with matched iso-
type controls. All monoclonal antibody solutions and isotype
controls were standardized to a concentration of 10g/mL
by dilution in staining buffer and 50L volumes were added
to the cell pellets. After vortexing and incubation on ice for
30min in the dark, cells were washed free of unbound anti-
body by two washes in staining buffer and subsequently
centrifugation. Surface stained lung DCs were resuspended in
0.5% PF/AD solution for analysis.
Statistical analysis
All data were analyzed using SPSS 10.0. Data are expressed as
means±SEM. Statistical analysis was determined by one-way
ANOVA or paired t test. A value of p<0.05 was considered as
statistically signiﬁcant.
Results
IAV infection can induce prompt and sustained increases
of the percentage of lung mDCs in MNCs
The expression of CD11c, HLA-DR, CD14, CD80, and CD86
was assessed by ﬂow cytometry analysis (FACS). Myeloid
dendritic cells (mDCs) were detected as the cells expressed
CD11c+, CD14−. On day 1 after IAV infection, the percent-
age of lung mDCs in lung MNCs promptly increased to
25.9± 2.9%,whichwas signiﬁcantly higher than that in control
RE
TRanimals (5.1± 2.9%, p<0.01, n=4). Thereafter, the percentages
of lung CD11c+CD14-mDCs declined slowly but maintained
signiﬁcantly high level until day 7. On day 30, the percent-
age of lung CD11c+CD14-mDCs was still higher than that incompared to the control group.
control animals, but this difference did not reach statistical
signiﬁcance (Fig. 1).
IAV infection can induce the maturation of lung mDCs
judged by up-regulation of co-stimulatory markers
To assess the maturation status of lung CD11c+CD14-mDCs
after IAV infection, the co-stimulatory markers such as
HLA-DR, CD80, CD83, and CD86 were analyzed by FACS. In
control group, the percentage of HLA-DR expressed from
lungCD11c+CD14-mDCswas 14.7%± 2.4%.After IAV infection,
the percentage of HLA-DR increased signiﬁcantly from day 1
(23.5%± 2.5%) to day 4 (39.5%± 3.9%) (p<0.01, n=4). There-
after, the percentage of HLA-DR dramatically decreased to
15.2%± 3.8% on d 30 (Fig. 2A).
Furthermore, we determined whether expressions of the
CD80, CD83, and CD86 systems are altered after IAV infection.
Compared to control group, the expressions of CD80, CD83,
and CD86 were up-regulated from day 1, almost peaked on
day 4. Then, these co-stimulatory markers were signiﬁcantly
decreased on day 7 after infection. On day 30, the expression
of CD83 expression returned almost to the baseline. However,
the expression of CD80 and CD86 was still higher than that in
control group (Fig. 2B–D).
IAV infection increased the percentage of lung pDCs in
MNCs
Here, we further investigated the immune response of lung
pDCs after IAV infection, and the percentage of pDCs in lung
MNCs was analyzed by FACS. On day 1 after IAV infection, the
percentage of lung CD11c-CD123+ pDCs in MNCs increased
CTto 4.1± 2.9%, which was higher than that in control group
(1.0± 2.9%, p<0.01, n=4). The percentages of lung CD11c-
CD123+pDCs increased slowly on day 3 and turned to the peak
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Fig. 2 – IAV infection induced the maturation of DCs in the lungs. The lung cells at different time point post IAV infection
were isolated and analyzed for the expression of a panel of surface markers that are related to the maturation status on
CD11c+CD14− DC. Mature DCs were analyzed for the expression of HLA-DR, CD80, CD83 and CD by ﬂow cytometry. The
percentages of CD11c+CD14-HLA-DR+ cells (A), CD11c+CD14-CD80+ (B), CD11c+CD14-CD83+ (C) and CD11c+CD14-CD86+ (D)
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ere calculated. Data are expressed as mean percentages±
ontrol group.
n day 4. Finally, the percentages of lung pDCs decreased to
aseline on day 7 post infection (Fig. 3A and B).
AV infection can induce gradual increases of the
ercentage of mDCs in the LALNs of NHPs
e next tested the number of mDCs in LALNs after IAV infec-
ion on days 1, 2, 3, 4, 7, and 30, respectively. Of note, the
ig. 3 – IAV infection induced the increases of pDCs (CD11c-CD12
AV infection were isolated and analyzed for ﬂow cytometry. (A)
nti-CD11c-APC (y-axis; log scale). Data shown are from represen
DCs after IAV infection. Data are expressed as mean percentage
o the control group.
RE
TR. * indicates p<0.05, ** denotes p<0.01 as compared to the
number of CD11c+CD14− mDCs started to increase on day
2, reached peak on day 7 and turned to decline on day 30,
which is similar to CD11c-CD123+pDCs observed in LALNs
after IAV infection. Unlike CD11c-CD123+pDCs, CD11c+CD14−
mDCs did not decrease below baseline amount during the
course of infection (Fig. 4A and F).
Expression levels of HLA-DR, CD80, CD83 and CD86 were
also observed in LALNs after IAV infection. One day after
3+) in the lungs. The lung cells at different time point post
Dot plots of anti-CD123-PE (x-axis; log scale) vs
tative monkeys in each group. (B) The changes of lung
s±SEM. * indicates p<0.05, ** denotes p<0.01 as compared
410 braz j infect d i s . 2014;18(4):406–413
Fig. 4 – The changes of mDC and pDC in the LALNs of monkeys following IAV infection. Cynomolgus macaques were
infected with IAV (H3N2) via bronchoscopy. The cells in LALNs were isolated and stained for ﬂow cytometry analysis at days
1–4, 7 and 30 following IAV infection (n=4/group). (A) CD11c+CD14− DCs began to increase on day 2 and sustained high
level until day 30 post infection. (B–E) The expressions of co-stimulatory markers such as HLA-DR, CD80, CD83 and CD86 on
the CD11c+CD14− DCs signiﬁcantly up-regulated following IAV infection. The matured DCs increased to the peak on day 7
post infection, but still maintained high level on day 30 post infection. (F) The pDCs (CD11c-CD123+) increased on day 4 and
day 7 post infection, then returned to normal level on day 30 post infection. * indicates p<0.05, ** denotes p<0.01 as
RE
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Dcompared to the control group.
infection, infected DCs showed severely increased HLA-DR,
CD80, CD83 and CD86 expression in the LALNs. However,
no statistical signiﬁcant difference between the infected
groups and the control group on day 30 has been detected
(Fig. 4B–E).IAV infection can induce the maturation of mDCs in
LALNs judged by up-regulation of co-stimulatory markersUltimately, we examined whether there was a functional cor-
relation between the IAV amount and the phenotypic changes
braz j infect d i s . 2014;18(4):406–413 411
Fig. 5 – The changes of mDC and pDC in the lungs of monkeys following infection with low dose or high dose of IAV virus.
Cynomolgus macaques were infected with two dose of IAV (H3N2) via bronchoscopy: low dose is 1×106 PFU, high dose is
2×106 PFU. The cells in lungs were isolated and stained for ﬂow cytometry analysis at days 1 and day 2 (n=4/group). The
results show that both the expression of CD86 on the CD11c+CD14− DCs and the number of pDCs (CD11c-CD123+) in high
dose group were signiﬁcantly higher than those in low dose group. However, the number of CD11c+CD14− and other
markers such as HLA-DR, CD80 and CD83 had not any changes. * indicates p<0.05, ** denotes p<0.01 as compared to low
dose group.
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Human peripheral blood contains two major DC populations,
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Dbserved in the infected DCs. As clearly seen in Fig. 5, high
ose of IAV can induce greater amount of CD80 and CD83
ompared to low dose of IAV by days 1 and 2 after infection.
owever, other phenotypic changes appear to have no sta-
istical signiﬁcance between low dose and high dose of IAV
nfection.Discussionnamely CD11c-CD123+pDCs and CD11c+CD123− mDCs. DCs
are APCs that act as a bridge between innate and adaptive
i s . 20
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immunity. DCs reside in peripheral tissues in an imma-
ture state, where they are on alert for invading pathogens
or other danger signals. A contact with nonself structures
such as microbes or their structural components activates
DC maturation, which is characterized by enhanced expres-
sion of co-stimulatory molecules, production of cytokines and
chemokines, and a change in the cell surface chemokine
receptor expression pattern. Moreover, maturation renders
DCs capable for efﬁcient antigen presentation to T cells.14
In the present study, we investigated the response of total
lung and LALN enriched DC subsets to IAV infection. Our
ﬁndings demonstrated that a signiﬁcant increase of DC num-
bers in IAV infected monkeys compared to the control groups
during the acute phase. Furthermore, our preliminary exper-
iments suggested that mDCs were extremely sensitive to the
IAV infection, expressing co-stimulatory molecules such as
HLA-DR, CD80, CD83 and CD86 in lungs. So in IAV infection,
numbers of pulmonary DCs were elevated during the acute
phase. Furthermore, mature mDCs were still sustained to day
30 post infection. Two days after infection with IAV, levels of
HLA-DR, CD80, CD83 andCD86were further increased. Strikin-
gly, CD83, a marker of mature DC, appeared on the cell surface
after IAV infection.19 The expression of all these surfacemark-
ers was then declined at day 4, but is was still higher than
those in the control group at day 30 post-infection.
In contrast, RSV infection caused only sustained increases
in numbers of mature dendritic cells in the lung.16 The
importance of DC in the initiation and control of innate and
adaptive immune responses against inﬂuenza infection iswell
documented.20–22 So they can effectively take up particulates
in the inﬂamed lung and migrate to the draining lymph nodes.
Meanwhile, following infection with IAV, both DC types
produced proinﬂammatory cytokines and chemokines23 that
can include IL-1, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, G-CSF, IFN-
, TNF- and so on. The mechanisms by which pDC surface
receptors recognize viral products have been widely reported
in some previous studies.24–26 Both retinoic acid inducible
gene I (RIG-I) and toll-like receptor 7 (TLR-7) pathways are able
to induce production of proinﬂammatory cytokines and type
I interferons (IFNs). RIG-I plays an important role in detecting
virus and producing IFNs in infected convention DCs, while
pDCs use the TLR-7 pathway for innate immune response
against IAV. Interestingly, in this present study, increased
numbers of pDCs have also been detected in LALNs after IAV
infection, suggesting that pDCs and mDCs can also transport
antigens from the infected lung to the draining lymph nodes
via the recognition of IFNs.
A hallmark for virus-infected pDCs is the production of
large amounts of IFN- accompanied with the production of
other proinﬂammatory cytokines. Most importantly, type I
IFNs possess potent antiviral properties and are critical to the
control of IAV infection. IFN stimulation induces transcription
of several IFN-responsive genes, many of which can protect
and interfere with the establishment of IAV infection in unin-
fected cells.27–29 Further, IFN stimulation can regulate innate
and adaptive immune responses through its ability to enhance
RE
TRDCs maturation as well as promote the survival and develop-
ment of effector functions by activated CD8 T cells.30–33
Actually, the activation state of DCs plays an impor-
tant role in the interaction between DC and T cell because14;18(4):406–413
non-activated DCs tolerate or delete T cells, whereas acti-
vation converts DCs to a stimulatory state that elicits T-cell
activation andmemory. Besides the role of APCs, the cytokines
and chemokines produced by pDCs and mDCs exposed to
viruseswould exert signiﬁcant autocrine and paracrine effects
in their microenvironments. However, infection with IAV may
also cause signiﬁcant pulmonary immune pathology, because
a cytokine storm, with unusually high levels of cytokines
in serum and lungs, is possibly correlated with inﬂuenza-
induced immune pathology and mortality.34 In the further
study, we will concentrate on the study of cytokines and
chemokines produced by DCs post IAV infection and analyze
their role in regulating the T-cell responses in lungs.
Altogether, we demonstrated that depending on the infect-
ing microbe, the functions of mDCs and pDCs may differ, and
may be partially overlapping, which suggests a considerable
ﬂexibility of the human DC system. A better understanding
of the interplay of IAV with DCs may facilitate the develop-
ment of an effective vaccine. Our ﬁndings may also provide
important insights to understanding the immune responses
of dendritic cells in response to IAV infection in a non-human
primate model.
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